ArticleCureus2022

Dabrafenib Plus Trametinib: An Impressive Response in an Adult Patient With BRAF V600E-Mutated and Isocitrate Dehydrogenase (IDH) Wild-Type Glioma.

Inês N Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.